PMS-Zolmitriptan ODT (2020-02-26)
- Starting date:
- February 26, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72463
Last updated: 2020-02-28
Summary
-
Product:
PMS-Zolmitriptan ODT tablet
Reason
Out of specification result for impurity stability.
Depth of distribution
Wholesalers, Retailers
Affected products
PMS-Zolmitriptan ODT tablet
DIN, NPN, DIN-HIM
DIN 02324768
Dosage form
Tablet (Orally Disintegrating)
Strength
Zolmitriptan 2.5 mg
Lot or serial number
615992, 615993, 615994
Companies
- Recalling Firm
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Related AWRs
